✦ LIBER ✦

Antibiotic prophylaxis of early onset pneumonia in critically ill comatose patients. A randomized study

✍ Scribed by A. Acquarolo; T. Urli; G. Perone; C. Giannotti; A. Candiani; N. Latronico

Publisher: Springer
Year: 2005
Tongue: English
Weight: 175 KB
Volume: 31
Category: Article
ISSN: 1432-1238
DOI: 10.1007/s00134-005-2585-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefits of a Synbiotic Formula (Synbiot

Benefits of a Synbiotic Formula (Synbiotic 2000Forte®) in Critically Ill Trauma Patients: Early Results of a Randomized Controlled Trial

✍ Katerina Kotzampassi; Evagellos J. Giamarellos-Bourboulis; Antonios Voudouris; P 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 133 KB

The tight calorie control study (TICACOS

The tight calorie control study (TICACOS): a prospective, randomized, controlled pilot study of nutritional support in critically ill patients

✍ Pierre Singer; Ronit Anbar; Jonathan Cohen; Haim Shapiro; Michal Shalita-Chesner 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 367 KB

Early antibiotic treatment (prophylaxis)

Early antibiotic treatment (prophylaxis) of septic complications in severe acute necrotizing pancreatitis: a prospective, randomized, multicenter study comparing two regimens with imipenem-cilastatin

✍ Enrique Maraví-Poma; Joan Gener; Francisco Alvarez-Lerma; Pedro Olaechea; Armand 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 160 KB

Lensen GL, Miller RH, Talabiska DG, Gian

Lensen GL, Miller RH, Talabiska DG, Gianferante L, ,A double-blind, prospective, randomized study of glutamine-enriched compared with standard peptide-based feeding in critically ill patients Am J Clin Nutr 64 (1996) 615 621.

✍ Jean-Fabien Zazzo 📂 Article 📅 1997 🏛 Elsevier Science 🌐 French ⚖ 210 KB

Golimumab, a human anti–tumor necrosis f

Golimumab, a human anti–tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four–week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis

✍ Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Str 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

Erratum: Golimumab, a human anti-tumor n

Erratum: Golimumab, a human anti-tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis

✍ Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Str 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 1 views